Considerable advances have been made in our knowledge of the molecular structure of cell adhesion molecules, their binding sites, and adhesion complexes. For the cadherins, protein zero, and CD2, additional experimental data support the insights obtained from structural analysis of their domains and molecular models of their adhesion complexes. For neural cell adhesion molecules, L1, fibronectin, tenascin-C, integrins, and vascular cell adhesion molecules, the molecular structure of domains, and in most cases their binding sites, have been elucidated. The substrate recognition sites in some of these molecules possess rate constants for association and dissociation that permit both rapid cell migration and, through avidity, high-affinity cell-cell interactions.
PERSPECTIVES AND OVERVIEW
In metazoa, differentiation of cell structures during development, tissue formation, and coordinated dynamic interactions of cells in various processes (such as the immune response) requires direct contact between cell surfaces and between cells and the extracellular matrix. The proteins through which these contacts are made are the cell adhesion molecules.
The first biochemical studies of cell adhesion molecules occurred more than two decades ago (1, 2) . Since then, these molecules have been the subject of thousands of papers, so a critical review must be restricted to only one aspect of the subject. An article on this topic appeared in this series in 1991 and examined the implications of cell adhesion molecules for molecular histology (3) . Here, the focus is on what is currently known about the molecular structure, binding sites, and adhesion complexes of cell adhesion molecules.
Most of the molecules discussed are built, at least in part, from immunoglobulin-like domains; hence, we begin with a general introduction to the structure of this superfamily. We then review the proteins involved in the formation and architecture of various solid tissues, including cadherins, neural cell adhesion molecules (NCAMS), the L1 cell adhesion molecule, and protein zero (P 0 ). Once complexes between these molecules are formed during differentiation, these contacts are generally stable for the life of the cells. We then discuss the extracellular proteins fibronectin and tenascin. Finally, we review proteins involved in the movement and interactions of leukocytes: integrins, vascular cell adhesion molecules (VCAMs), and CD2. All the structural information we discuss has become available during the past five years, most within the past year. Two other recent reviews also present some aspects of this work (4, 5) .
Not discussed here is the complex between the T-cell αβ receptor and MHC molecules. Recent work on the V α -C α (6) and V β (7) domains of T-cell αβ receptors has provided the first direct information on their molecular structure. Although these results are of great interest, we expect further work to be published in the near future that makes inclusion of this topic somewhat premature. Also not discussed here are proteins involved in carbohydrate recognition, which have been described in three excellent and recent reviews (8) (9) (10) .
IMMUNOGLOBULIN SUPERFAMILY DOMAINS

The V, C1, C2, and I Sets
Of the nine cell adhesion molecules discussed here, five (NCAMs, L1, P 0 , CD2, and VCAMs) are built wholly or largely of domains that belong to the immunoglobulin superfamily (IgSF). Therefore, we discuss the classification and structural relationships of the different IgSF domains in these proteins.
Sequences of IgSF members are diverse: Residue identity between domains within individual proteins, and among related domains in different proteins, is often in the 10-30% range. Although these domains all have a similar core structure formed by two β-sheets packed face-to-face, other features of the structures can display considerable variation. The peripheral regions-the edge strands of the β-sheets and the loops that link strands-can have quite different conformations. For the most distantly related domains, more than half of each structure is comprised of peripheral regions that have different folds (11) .
Although IgSF members are diverse, inspection of the first structures to be determined showed that they could be grouped into related sets (12) . Members of a given set have peripheral regions whose conformations are very similar, even though sequence identity is low. In the original classification of IgSF domains, three sets were identified: V, C1, and C2. The first two were classified on the basis of known structures, the third on the basis of certain sequence characteristics that did not fit the known structures (12) . Subsequent structure determinations showed that the sequence characteristics originally defined for "C2" domains are shared by proteins that actually form two sets of distinct structures: a redefined C2 set and a new I set (13) . Figure 1 shows schematic diagrams of the structure usually common to the members of each set. There are distinct differences among the common structures of the different sets, as can be seen if the diagrams are superimposed ( Figure 1 ). In terms of strands only, and taking the I-set structure as a reference point, the V set has an additional C strand, the C1 set lacks the A strand, and the C2 set lacks the A and the D strands. There are also differences in the length of strands common to different sets. For example, as shown in Figure 1 , the strands extend further toward the upper part of the structure in the C1 set than in the other sets, and the strands extend further toward the lower part of the structure in the I and V sets than they do in the other sets.
Each of the IgSF domains in the cell adhesion molecules discussed here can be readily assigned to one of these sets. The NCAM and L1 domains, and domain 1 of VCAM, belong to the I set; P 0 and domain 1 of CD2 belong to the V set; and domain 2 of CD2 and of VCAM belongs to the C2 set. When a domain in a cell adhesion molecule is assigned to the I, V, or C2 set, this Annu (b) Figure 1 The structural sets of the immunoglobulin superfamily. The structure that is usually conserved in the V, C1, C2, and I sets is shown (a, top of b). Solid circles represent β-sheet residues, open circles represent residues in conserved loops, and horizontal broken lines represent hydrogen bonds. β-sheet strands are labeled A, A , B, C, C , C , D, E, F, and G. The C1-set structures do not have strands A and C ; the C2-set structures do not have strands A , C , and D; and the I-set structures do not have the C strand. To help compare the structures of the different sets, the sites usually occupied by the Cys residues that form the intersheet disulphide bridge are indicated by diamonds. These Cys residues are strongly conserved in the V and C1 sets but less so in the I and C2 sets. To illustrate the differences in the structures, the I, V, and C1 sets are superimposed (b, bottom). In this part, filled circles represent sites common to the I, V, and C1 sets; V, C1, and I represent sites conserved in those sets.
classification means that its structure is similar to one of those illustrated in Figure 1 , except that, in some cases, the extent of some strands is somewhat greater. In those instances, any important differences are described. A broader classification than that described above has been proposed (14) that encompasses IgSF members and all of the other proteins that have the same fold (i.e. proteins that have the same major secondary structure in the same geometrical arrangement and with the same connections as those found in an IgSF member). This new classification includes fibronectin type III domains, the chaperone PapD, and domains from certain bacterial enzymes. The structural similarity of these proteins may reflect evolutionary relationships or may arise fortuitously from the fact that the physics and chemistry favor certain types of folds in proteins. Four classes are defined: v, which corresponds to the V set; c, which corresponds to the C1 set; s, which corresponds to the C2 set but includes the fibronectin type III domains and PapD; and h, which covers certain bacterial domains (14) .
Prediction of the Structure of IgSF Domains
Conformation of a protein is determined mainly by the set of key residues that are involved in intramolecular packing and hydrogen bonding and/or those that are able to take up an unusual configuration. If two proteins have homologous sequences, they will have similar structures in their core regions (13, 14a) . The degree of structural similarity beyond the core depends on the extent to which the different proteins conserve sequence length and key residues in other regions. If these other regions are the same size, and if the key residues that determine the known conformation in one protein are also present in a homologous protein (or if suitable alternative residues are present), the region in question will have the same or a very similar three-dimensional structure in both proteins. If the key residues (or suitable alternatives) are not present, or if insertions or deletions occur, the regions in question will have different conformations (11) (12) (13) 15) .
Knowledge of the key residues within a particular structure allows a reasonable deduction to be made about whether that same structure is conserved in homologs that have only low sequence identity (i.e. 10-20%) (12, 13) . Determination of the key residues in an I-set protein, "telokin," led to the prediction that many of the corresponding IgSF domains in cell adhesion molecules, surface receptors, and muscle proteins would also have I-set structures (13) . Subsequent structure determinations showed this conjecture to be true for the domain 1 segments of VCAMs and NCAMs, and for the IgSF domains in the muscle proteins, titin and twitchin (see below; 15, 16).
Evolution of the Immunoglobulin Superfamily
Comparison of the IgSF sets illustrated in Figure 1 shows that the I set has a structure that combines features of the structures of the V, C1, and C2 sets: The I set resembles the V set on the A -side of the structure and the C1 set on the C -side of the structure. This intermediate nature of the I set suggests that it could be the ancestor of the V, C1, and C2 sets.
This view is supported by evidence from phylogenetic comparison of IgSF members. For example, bacterial members belong to the I set (17) , as does a domain found in marine sponges (18; A Bateman & C Chothia, unpublished data), and IgSF domains in the proteins from Caenorhabditis elegans (15) . The V-, C1-, and C2-set structures, on the other hand, seem to be confined to descendants of the common ancestor of cartilaginous fishes (sharks and rays) and humans. Conclusions drawn from such phylogenetic comparisons are tentative because of the incomplete nature of currently available sequence data. Nevertheless, the I-set structure appears to be the precursor to the modern IgSF (see also 3, 12) .
CADHERINS
Cadherins are adhesion molecules involved in embryonic morphogenesis and the formation of stable interactions among the cells in solid tissues and in epithelia (19, 19b) . Nearly all forms have five homologous extracellular domains (Figure 2a ), a single membrane-spanning segment, and a cytoplasmic region that is anchored through catenins to cytoskeletal actin microfilaments (20) .
Cadherins are found in animals ranging from nematodes to humans. Higher organisms as a group contain several types of cadherins. Each cadherin type confers on the cell in which it is expressed specific cell adhesion properties (21) . In adhesion, cadherin dimers on one cell make homophilic contacts, through domain 1, with cadherin dimers on another cell (22) . Thus, domain 1 dictates binding specificity. Both dimerization and adhesion are calcium dependent. In the absence of calcium, a cadherin molecule is monomeric (with the extracellular domains displaying extensive motion relative to each other) and is unable to form adhesion complexes (23) .
Structure of Cadherin Domains
Structures have been determined for domains 1 (24, 25) and 2 (25) of murine epithelial (E) cadherin and for domain 1 of murine neural (N) cadherin (26) . All three domains have the same overall structure: seven strands of β-sheet (A , B, C, D, E, F, and G). In the case of domain 1 of N-cadherin and domainhave the same conformation. It is only the residues forming the loops that link the strands in domains 1 and 2 that differ in conformation to varying degrees.
The sequences of domains 3, 4, and 5 have decreasing numbers of identities in comparison to the sequences of domains 1 and 2: as little as 10-16% in the case of domain 5. Nevertheless, alignments of the sequences of domains 3, 4, and 5 onto the known structures of domains 1 and 2 indicate that the core β-sheet structure is most likely conserved in all three domains (24, 27) . The regions involved in binding calcium (see below) are also conserved. On the other hand, the loop regions at equivalent positions in different domains show very little conservation in sequence, length, or predicted conformation.
Calcium-Binding Sites
The most complete picture of the sites for binding of Ca 2+ and the effect of Ca 2+ -binding on the organization of cadherins is provided by the structure of domains 1 and 2 of E-cadherin (25) . Domain 1 (residues 1-99) is linked by a seven-residue segment (residues 100-106) to domain 2. Three Ca 2+ bind in this linker region (Figure 2c ). One ion is bound by residues Glu-11, Asp-67, and Glu-69 in domain 1 and by Asp-103 in the linker. The second is bound by residues Asp-134 and Asp-136, the main chain oxygen of residue 143, and Asp-195 in domain 2 and by Asn-102 and the main chain oxygen of residue 104 in the linker. The third Ca 2+ is bound by all three regions: Glu-11 and Glu-69 in domain 1; Asp-100, the main chain oxygen of residue 101, and Asp-103 in the linker; and Asp-136 in domain 2. Of the twelve residues that bind to Ca 2+ , four bind to two ions. These extensive interlocking interactions fix the relative orientation of the two domains (25) . Examination of the sequences of domains 2, 3, 4, and 5 shows that equivalent calcium-binding residues are conserved (25) . Conservation is particularly striking in the regions linking the domains. It is likely, therefore, that calcium occupies similar sites at the interfaces between domains 2 and 3, 3 and 4, and 4 and 5. A proposal that these regions bind calcium was made in 1987 (28) . The interactions provided by Ca 2+ confer a rigid conformation on the five domains. Removal of calcium eliminates these interactions, leaving the domains connected by flexible linkers. 
Dimer Formation
In crystals of domains 1 and 2 of E-cadherin, dimer formation involves parallel association of two molecules (25; Figure 2c ). The contacts at the interface are made by the A-AB-B region of domain 1, the linker region, and the BC and FG turns of domain 2 (some 19 residues in all) (25) . Each molecule buries 940 A 2 of surface at the interface (i.e. the total buried surface is 1880Å 2 ). Of this total, 45% comes from residues in domain 1, 20% from residues in the linker region, and 35% from residues in domain 2.
Given the structure of this interface, and the assumption that the relative orientations of the other three domains within a native molecule is the same as that for domains 1 and 2, a dimer of the whole molecule would yield a V-shaped structure for the extracellular portion of the protein, with association only occurring at the domain 1-domain 2 interface (Figure 2a ). In this model, each arm would be 240Å in length, close to the 220Å determined by electron microscopy (25) .
The Adhesion Complex
The molecular contacts in the crystal of domain 1 of N-cadherin provide a model for the interactions in the homotypic adhesion complex (26) . The domain 1-domain 1 association is antiparallel, in which 15 residues in each domain are in contact with, or very close to, the other domain. These residues are in the C strand, the CD loop, the D strand, the F strand, and the FG turn (Figure 2d ). The D strand of one domain packs against the FG turn of the other domain, and vice versa. Likewise, the C strand and CD loop residues are in contact with each other. There are also a number of water molecules in or around the interface that make contacts or hydrogen bonds that bridge both domains (26) . The residue contacts at the interface bury 1300Å 2 of surface; if the contributions of water molecules bound in and around the interface are considered, the buried area is 3300Å 2 (26) . Given its structure, each cadherin dimer on one cell can make adhesion contacts with two cadherins on a second cell (26; Figure 2a ). This lateral association between the domain-1 regions of different molecules can be repeated to form a zipper-like structure in which multiple cadherins on a pair of cells are interlocked via domain 1-domain 1 interactions.
In addition to its function in homophilic cell-cell adhesion, E-cadherin is a ligand for the integrin αEβ7 (28a). This integrin is expressed on the surface of T cells found in the vicinity of mucosal epithelia. The binding site region in E-cadherin has been identified by domain deletion experiments and engineered mutations (28b) . These show that E-cadherin requires domains 1 and 2, and Glu-31 (a residue in the BC loop of domain 1), to bind to the integrin. Glu or Asp residues in exposed or extended loops are common features of sites that bind integrins (see below; Figures 6 and 8) .
Calcium Regulation and the Specificity of Adhesion
The recognition sites of close-packed protein-protein complexes usually bury an area of 1650 ± 350Å 2 at the interface, in those cases that do not involve a large conformational change (29) . When complex formation does involve a large conformational change, or a transition from disordered to ordered structures, much larger contact areas are required (29, 30) . The buried areas at the interfaces of the cadherin dimer (1880Å 2 ) and adhesion complexes (1300Å 2 ) are typical of simple protein-protein complexes.
As discussed above, the dimer interface is formed by the linker regions and adjacent parts of domains 1 and 2, and calcium ions are essential to the structure of this region. The Ca 2+ brings together carboxylate side chains that would otherwise repel each other, and thus give the region the ordered structure required for formation of the dimer interface. Formation of the dimer is, in turn, a prerequisite for formation of intermolecular adhesion contacts (31).
As mentioned above, each cadherin subtype has a unique homophilic binding specificity that confers on the cell in which it is expressed a specific adhesion propensity. Alignment of the domain-1 sequences of different cadherin subtypes shows that adhesion specificity is almost certainly produced by differences in the residues that form the proposed adhesion interface (26; Figure 2d ). Of the 15 residues involved in adhesion contacts in N-cadherin, some are conserved, but most are very different, at the equivalent sites in other cadherins. Indeed, for these 15 residues, in N-and R (retinal)-cadherins, which are unusual because they display heterophilic interactions with each other, there are only three conservative substitutions; in N-and E-cadherins, which do not interact, there are two conservative and four nonconservative differences (26) .
NEURAL CELL ADHESION MOLECULES
NCAMs are cell-surface proteins that, through homophilic interactions with molecules on other cells and heterophilic interactions with molecules on the same cell, play a central role in regulation, organization, and maintenance of the associations made by embryonic and adult neurons and their target tissues (32) . NCAM sequences from vertebrates, ranging from humans to frogs, share residue identities of 70% to 98%. More distantly related are the fasciclins II of grasshopper and fruit fly (Drosophila melanogaster) and the Aplysia californica cell adhesion molecule (ApCAM), which have only 25% identity to vertebrate NCAMs (33) (34) (35) .
Examination of the gene structure, cDNA sequence, and amino acid sequence of these proteins shows that different isoforms arise from differential exon usage (36, 37) . The simplest structure, the 120-kDa form, consists of five IgSF domains (Ig 1-Ig 5) followed by two fibronectin type III (FnIII) domains and a 30-residue C-terminal segment. This isoform is anchored to the cell surface through linkage to glycosyl phosphatidylinositol. The other major isoforms have a transmembrane helix (the 140-kDa form) or a transmembrane helix and a cytoplasmic domain (the 180-kDa form).
There are also two isoforms that involve changes within the Ig and FnIII domains. One contains a 10-residue segment (VASE or π peptide) (38) inserted in the region that links the C and D strands of Ig 4. This insertion changes the function of NCAMs from molecules that promote morphological plasticity to molecules that maintain stable cell-cell contacts (39) . The other isoform is muscle specific, in which a 31-or 36-residue segment is inserted in the region linking the two FnIII domains (37, 40) ; this isoform may be involved in early myofibrillogenesis (41, 42) .
Structure of the NCAM Domains
The structure of the Ig-1 of human NCAM has been determined (43) . It has an IgSF I-set structure with one β-sheet containing four strands (A, B, E, and D) and the other β-sheet having five strands (A , G, F, C, and C ) ( Figure 3 ). The overall conformation of this domain is that found in other known I-set structures (43) . Alignment of the sequences of the Ig-2-Ig-5 domains of NCAM with that of the Ig-1 domain shows that all have the same (or similar) residues at most of the sites that are key for determining the observed conformation of the Ig-1 domain. These close matches at key positions imply that the structures of the Ig-2-Ig-5 domains are likely to be very similar to that of the Ig-1 domain over at least 80% of their tertairy fold (NK Thomsen, Y Harpaz, FM Poulsen & C Chothia, unpublished observations).
No direct structural information is available for the two FnIII domains in NCAMs. Structures have been determined, however, for two FnIII domains found in neuroglian, a D. melanogaster homolog of the L1 cell adhesion molecule (45; see below). Alignment of the NCAM FnIII sequences with those of the neuroglian domains shows sufficient identity and similarity at the positions critical for FnIII structure to imply that the NCAM FnIII domains will most likely have largely the same conformation as those in neuroglian (NK Thomsen, Y Harpaz, FM Poulsen & C Chothia, unpublished observations).
General Structure of NCAM
The main features of the arrangement of the domains in NCAM have been obtained from electron microscopy of rotary-shadowed preparations (46) . Several NCAM isoforms were examined. The isoform that consists of the five Ig domains, the two FnIII domains, and the 30-residue C-terminal peptide gives images with the appearance of a bent rod approximately 45Å thick, with one arm of approximately 180Å, and the other of approximately 100Å. The longer arm was identified as the N-terminal part of the molecule. The conclusion drawn from these data is that the Ig domains form a rod structure (180Å long) linked to another rod structure (100Å long) formed from the FnIII domains and the C-terminal peptide. The angle between the two arms varied from 50
• to 140
• , suggesting that the two arms are linked by a flexible hinge (46) .
The NCAM Adhesion Complex
The general structure of the homophilic complex of NCAMs has been deduced from measurements of the ability of single Ig domains to bind to each other and to the whole molecule (47) . In solution, the highest affinity found is that between two Ig-3 domains, followed by the affinity of Ig-2 for Ig-4 and then that of Ig-1 for Ig-5. Other domain pairings show little or no affinity. These results suggest that homophilic recognition by NCAMs involves antiparallel association of the five Ig domains of one molecule with the five Ig domains in another NCAM (Figure 3a ).
L1 AND NEUROGLIAN CELL ADHESION MOLECULES
The L1 cell adhesion molecule (L1) is a cell-surface glycoprotein that has an important role in neurogenesis, nerve growth, and fasciculation. The activities of this molecule are mediated by its homophilic interactions with other L1 molecules on other cells, as well as by its heterophilic interactions with axonin 1, a protein that has a sequence similar to that of L1 (48, 49) . In humans, mutations in the L1 gene cause X-linked hydrocephalus and other clinically related genetic diseases (50) . The extracellular portion of L1 is composed of six IgSF domains followed by five FnIII domains (Figure 4a ). These domains are linked by a transmembrane helix to a small intracellular domain (51) . L1 sequences from a number of vertebrates share sequence identities of 50-85% with that of human L1 (52, 53) . The D. melanogaster protein, neuroglian, whose function is related to that of L1, has the same domain structure and possesses 25% identity to human L1 (54) .
Structure of Immunoglobulin Superfamily Domains in L1
A model for the tertiary structure of the extracellular domains of human L1 was derived on the basis of their homology to proteins of known structure (55) . The sequences of the L1 Ig domains were aligned with that of telokin, an IgSF I-set domain of known structure. At many of the positions that determine the conformation of telokin, the equivalent sites in the L1 domains have the same residues (or suitable alternatives). The alignments suggest that ≥75% of the structure of each L1 Ig domain will have the same conformation as telokin: two β-sheets, one with strands A, B, E, and D, and one with strands A , G, F, C, and C ( Figure 4b ). Conservation of other key residues implies that certain loops (A B, BC, EF, and FG) in all or some of the L1 domains will have conformations similar to those found in telokin (55) .
Structure of the Fibronectin Type III Domains in L1
The crystal structure of a neuroglian fragment containing the first two FnIII domains has been determined (45) . Each domain has a basic structure common to other FnIII domains: seven strands that form two β-sheets-one with three strands (ABE), and one with four (GFCC ) (Figure 4d ). On a more detailed level, the neuroglian FnIII domains have some unusual features. In the first domain, the G strand is interrupted by nine residues that form three turns of polyproline II helix ( Figure 4c) ; the second domain has one such turn in this region. The C -strand in the first domain also has three adjacent β-bulges (Figure 4d ). The interface between the two domains is formed by a four-residue segment that links the two domains, residues in the EF and CC turns of domain 1, and the BC turn of domain 2 (45) . The interface between the domains buries 770Å 2 of protein surface. A metal ion also is present in the interface between the domains (Figure 4c ). The ion has five ligands: Oγ of Ser-679 and the main-chain O of Pro-680 from the EF loop of domain 1, Oδ of Asn-743 and the main-chain O of Ile-740 from the BC loop in domain 2, and the O of a water molecule. Bond lengths and the protein crystallographic data indicate that the metal is sodium. The residues whose side chains ligate to Na + in this structure are not conserved in the other FnIII domains of neuroglian, suggesting that the metal binding site is unique to the interface between domains 1 and 2. In the section on Fibronectin, below, we compare the geometry of the connection between the two neuroglian FnIII domains to that found in other FnIII proteins.
Alignment of the amino acid sequences of the FnIII domains in human L1 with the two neuroglian FnIII sequences indicates that all or part of strands A, B, C, E, F, and G (and several of the EF and FG loops) in all of the L1 FnIII domains will most likely have conformations similar to those in neuroglian (55) . In domains 1 and 2 of L1, the residues that constitute the metal binding site in neuroglian are conserved.
Mutations in L1 that Cause Neurological Diseases
Mutations in the human L1 gene (located on the X chromosome) give rise to X-linked hydrocephalus and related disorders (50) . Among the mutations characterized to date are frameshifts, stop codons, base changes that prevent proper mRNA processing, and missense mutations that cause single amino acid substitutions. Of the 26 missense mutations identified (56), 22 occur in the Ig and FnIII domains of L1. Seventeen of the mutations are spread throughout the six Ig domains, and five mutations are found in various FnIII domains. The likely effect of these 22 mutations can be assessed using the outline structure of L1 (55) . Thirteen substitution mutations occur at positions that are predicted to disrupt domain stability because these sites are highly conserved in L1 homologs ranging from D. melanogaster to humans, and because the mutations produce drastic changes in the size or chemical character of the corresponding residue.
The other nine mutations alter surface-exposed residues and produce other effects. For example, two mutations introduce a surface Cys residue that may affect L1 function through the inappropriate formation of intra-or intermolecular disulphides. One mutation introduces a Pro, which presumably disrupts β-sheet structure. The other six mutations alter the surface properties (charge, hydrophobicity) of the domains.
Nine mutations are clustered in parts of the structure closest to the N terminus of a domain, and seven of these may affect interactions between domains. Four mutations, three in the Ig-2 domain and one in the Ig-4 domain, are in the C D region.
The effects on homophilic binding activity of two mutations (R184Q and H210Q) in the Ig-2 domain of L1 have been measured (57) . The R184Q mutation, which occurs at a residue expected to be important for domain stability, eliminates homotypic binding, whereas the H210Q mutation, which is predicted to affect a surface-exposed residue, has a modest effect on binding.
PROTEIN ZERO
Protein zero (P 0 ) is the major protein component (up to 80%) of the cell surface of the myelin sheaths of peripheral nerve cells in vertebrates (58) . In sharks, P 0 is found in the myelin sheaths of both the peripheral and central nervous systems (59) . The P 0 molecule contains an extracellular region consisting of a single IgSF domain, a single membrane-spanning helix, and an intracellular domain (60, 61) . P 0 is a homophilic cell adhesion molecule. Interactions among the extracellular domains of P 0 molecules in adjacent membranes are believed to be responsible, in part, for holding together individual wraps of the myelin sheath (62); likewise, interactions among the intracellular domains of P 0 molecules are thought to mediate the apposition of the cytoplasmic faces of the myelin membrane (63) .
Structure of the Extracellular Domain of Protein Zero
The crystal structure of the extracellular region of rat P 0 has been determined (64) . It consists of a single IgSF V-set domain with the standard two β-sheets formed from strands A, B, E, and D, and strands A , G, F, C, C , and C , respectively (Figure 5b ). The structure is very similar to the V domain of a typical antibody. Of the 119 residues in the P 0 extracellular domain, 90 have the same conformation as the equivalent residues in an immunoglobulin V domain. All the differences are in loop regions, and the only major one is an extended BC loop in P 0 that protrudes beyond the body of the domain into solution and has a highly exposed Trp-28 at its tip (64) . The extracellular domain is tethered to the transmembrane helix by a five-residue connector.
Oligomerization and Adhesive Interactions
The extracellular domain of rat P 0 crystallizes under near physiological conditions. This fact, along with data from analytical ultracentrifugation and electron microscopy, strongly supports the proposal that the two types of molecular contacts observed in crystals of P 0 correspond to two modes of interaction involved in the cell adhesion function of P 0 (64) .
In the first type of contact, four molecules are clustered in parallel about a crystallographic fourfold axis to form a hollow ring (Figure 5c tetramers, the BC loop of one molecule interacts with the C D and EF loops of the next. These contacts bury some 600Å 2 of solvent-accessible area at each interface. If envisioned as a disk, the tetramer has, on one side, the C termini of each monomer, which are all at the same level and pointing in the same direction, and on the other side, the protruding BC loops with their exposed Trp-28. Given that the C terminus of each extracellular domain is attached to its cognate transmembrane anchor, the observed spatial arrangement would allow the four molecules of a tetramer to be tethered to the same cell surface (Figure 5a ). Given their abundance, similar tetramers of P 0 are likely to coat the surface of the myelin membranes (64) .
The second form of interaction seen in P 0 crystals provides a model for homophilic cell adhesion. Individual monomers tethered to one cell membrane associate in an antiparallel manner with monomers tethered to an opposing cell membrane (Figure 5a and d) . This means that a tetramer on one membrane makes contacts with four tetramers on the opposing cell membrane and vice versa ( Figure 5c ). As in CD2 (see below), the interaction is symmetric, mediated by the surface of the GFCC C sheet in both molecules. However, the geometry of the interaction in the P 0 contacts differs from that of CD2 in that the relative directions of the opposed strands are now antiparallel rather than orthogonal. accessible surface area buried at this interface is some 980Å 2 with a major contribution being made by an antiparallel pairing of the C -strands. In addition, the Trp-28 residue in the extended BC loop in each monomer is positioned to penetrate the membrane of the opposing cell (Figure 5a and d) .
The areas buried in the P 0 interaction (600 and 980Å 2 ) are smaller than those found in high-affinity complexes between soluble proteins (29) . However, attachment of P 0 to the membrane, and the very high concentration of P 0 on the intermembrane interface, most likely compensates for weaker interactions between individual monomers (see also the discussion in the Conclusion section).
The dimensions of the stack of two antiparallel P 0 tetramers in the proposed adhesive interaction are similar to the intermembrane spacing (46Å) observed in myelin sheaths (65, 66) . The 46-Å gap is equivalent to the distance between the prominently exposed Trp-28 side chains on opposed BC loops ( Figure 5a) ; it is argued, therefore, that insertion of the Trp-28 side chain that protrudes from a P 0 monomer on one membrane into the surface of the opposite membrane (64) determines the intermembrane distance in the myelin sheath.
Mutations in Protein Zero that Cause Neurological Diseases
Two human genetic diseases, Dejerine Sottas syndrome and Charcot-MarieTooth disease type 1B, have been linked to mutations in the P 0 gene (67, 68) . Currently, 16 mutations in the extracellular domain are known. Mapping these mutations on the structure suggests that they disrupt folding of the extracellular domain (e.g. deletions in the β-strands or large changes in buried residues) or disrupt contacts at the oligomer and the adhesive interfaces (64) . A particularly severe disease phenotype results from a Ser-34-Cys substitution (69) that would result in a surface-exposed Cys. As also observed in genetic diseases linked to L1 (see above) and the fibroblast growth factor (FGF) receptor (70) , it is proposed (64) that the Cys residue causes dysfunction through formation of inappropriate disulphide bonds.
FIBRONECTIN
Fibronectin is deposited in a variety of extracellular matrices (ECMs). The primary role of fibronectin is to attach cells to the ECM by binding to members of the integrin family of cell-surface proteins; however, fibronectin is a multifunctional protein that also binds to other constituents of the ECM, including fibrin, collagen, and heparin. Fibronectin is involved in embryonic differentiation, cell morphology, cell migration, and thrombosis (71) .
Fibronectin is a long flexible molecule (72, 73) . It is usually a dimer with its subunits joined by two disulphide bridges near their C termini. The structure of the dimer contact region around the disulphides has been determined and is formed by 10 residues that coil and associate in an antiparallel manner (74) . Each fibronectin chain is comprised of four types of structural elements: fibronectin type I (FnI), type II (FnII), and type III (FnIII) domains, and the V domain. In the major fibronectin species, these domains are arrayed so that six type I domains are followed by two type II domains, three type I domains, fourteen type III domains, the V domain, one type III domain, and three type I domains (71; Figure 6 ). Alternative gene splicing can give rise to fibronectin molecules that contain additional type III domains (one after the seventh and one after the eleventh Fn III) or in which the size of the V domain is modified or removed altogether (75) .
Structure of the Fibronectin Type I and Type II Domains
The 12 FnI domains (each with ∼40 residues) share sequence identities of about 35%. Structures have been determined for the first and seventh FnI in isolation (76, 77) and for a fragment harboring both the fourth and fifth ( 4 FnI-5 FnI) (78) . The structure of an FnI domain found in tissue-type plasminogen activator has been determined in isolation and in a fragment also containing its neighbouring epidermal-growth-factor (EGF)-like domain (79, 80) . All five of these FnI structures have two small β-sheets packed face-to-face. The first β-sheet is formed by the first two strands (A and B), and the second β-sheet is formed by the next three strands (C, D, and E) ( Figure 6 ). Conserved disulphide bridges join strands A and D and also strands D and E. The residues that pack to form the interior in the four fibronectin structures are highly conserved in the sequences of the other eight domains; it is expected, therefore, that the other FnI domains have structures very similar to those that are known. In the different FnI domains, however, the loops joining the strands show small variations in size and conformation.
In the structure of 4 FnI- 5 FnI, the second β-sheet of the 4 FnI packs against the first β-sheet of the 5 FnI. Thus, the four β-sheets in the two domains stack on top of each other to produce a rod-like structure (78; Figure 6 ). In other FnI sequences, the residues equivalent to those that form the interface between 4 FnI and 5 FnI are not strongly conserved; therefore, it is uncertain whether other pairs of FnI domains pack in the same manner (78) . Although FnI domains have very similar folds, their target recognition properties differ. Ligand binding also usually involves more than one domain. 4 FnI- 5 FnI is the main fibrin-binding site (82) . 8 FnI- 9 FnI and 2 FnII-7 FnI are the major collagen-binding sites (83, 84) . No structure has yet been determined for either of the two FnII domains. However, the 40-residue collagen-binding b domain of the bovine seminal fluid protein, PDC-109, is clearly homologous to FnII. The structure of the collagenbinding domain in PDC-109 has five short strands of β-sheet (81); strands B, A, and D form one β-sheet that packs at nearly right angles to the second, which is formed by strands C and E ( Figure 6 ). The cavity formed between the two β-sheets is thought to be involved in binding collagen (81) .
Structure of Fibronectin Type III Domains
Structures have been determined for the 10 FnIII in isolation (85, 86) and for a segment containing 7 FnIII-8 FnIII-9 FnIII-10 FnIII (87). All of these domains have a similar structure: two β-sheets packed face-to-face-one sheet formed by strands A, B, and E, and the other by G, F, C, and C (Figure 4d ). In the four domains, the β-sheets are very similar; the largest difference is whether the A strand contains a second β-bulge and where that bulge is positioned. In an alignment of all the FnIII sequences in fibronectin (86) , it was suggested that (a) each would have a β-sheet structure and, in most cases, conformations for the C E and EF turns very similar to those seen in turns would vary in size and conformation. These predictions were confirmed for 7 FnIII-9 FnIII by their subsequent structure determination (87) .
Connections Between FnIII Domains in Fibronectin and Other Proteins
In Table 1 , the interdomain geometries of pairs of FnIII domains are described in terms of (a) a tilt angle (the angle between the long axes of adjacent domains) and (b) a rotation angle (the rotation required to superimpose adjacent domains) (87) . The β-sheet frameworks of the 7 FnIII, 8 FnIII, 9 FnIII, and 10 FnIII domains are connected by five-residue linkers. The connection between the two FnIII domains in neuroglians is four residues. Although the lengths of the connections between FnIII domains in fibronectin are conserved, the interdomain geometries vary ( Figure 6 ; Table 1 10 FnIII, however, the tilt angle and the rotation angle are much smaller (Table 1) .
The interface between pairs of FnIII domains involves the linker peptide, residues in the AB and EF loops on one FnIII, and residues in the BC or FG loop on the other FnIII. Variations in the volume or chemical character of the residues in these interfaces explain the observed differences in the interdomain geometries (87) .
The Integrin-and Heparin-Binding Sites
The function of fibronectin as a cell adhesion molecule involves its recognition by integrins. The sites for fibronectin interaction with integrins reside in 9 FnIII and 10 FnIII. The site in 10 FnIII involves an Arg-Gly-Asp (RGD) sequence in the FG turn (88) . In 10 FnIII, the FG turn is three to five residues longer than in any other FnIII domains, and the RGD tripeptide is located at the end of the loop, some 10Å away from the body of the domain (85-87; Figure 6 ). A second site of interaction with integrins, the "synergy" site, has been identified on 9 FnIII in the C E region (89, 90; Figure 6 ). The different elements in this region are important for discrimination by different integrins. Residues Asp-1373 and Arg-1374 are essential for interaction with integrin α IIb β 3 but not with integrin α 5 β 1 (90) , whereas Arg-1379 is important for interactions with integrin α 5 β 1 but not with integrin α IIb β 3 (89) .
The site for heparin-binding on 13 FnIII has been examined by site-directed mutagenesis and involves six Arg and one Lys situated mainly on the A and B strands of one β-sheet (91, 92) .
TENASCIN-C
Tenascin-C is one of a family of three tenascins, which are homologous hexameric proteins found in the ECM (93) . Each tenascin-C polypeptide contains an N-terminal domain, 13.5 EGF-like domains, 8-15 FnIII domains (depending on the splice variant), and a C-terminal domain (94) . The six subunits are joined together at their N-terminal ends to give a hexabrachion structure resembling the spokes of a wheel projecting from a central hub (95) . The biological function of tenascin is uncertain, but it does have integrin-binding sites, one of which is situated on the third FnIII domain that contains an RGD sequence. The structure of this FnIII domain is very similar to the FnIII domains in fibronectin (87, 96) . The RGD tripeptide in the FG turn of the third FnIII domain in tenascin-C is like that in 10 FnIII of fibronectin ( Figure 5 ). In tenascin-C, however, the FG loop is four residues shorter, which brings the RGD tripeptide 7Å closer to the body of the domain. This RGD site in tenascin-C can bind to integrin α 5 β 3 but not to integrin α 5 β 1 (97) . A second site for cell binding is found in the C-terminal FnIII domain of tenascin-C and is probably recognized by integrin α 2 β 1 (97, 98) .
INTEGRINS
Integrins constitute a large, widespread family of cell adhesion molecules implicated in biological functions such as embryogenesis, the immune response, haemostasis, inflammation, and maintenance of tissue integrity. Integrins bind not only to components of the ECM, including fibronectin (see above), collagens, and laminin, but also to other cell adhesion molecules, including VCAM-1 and the intercellular adhesion molecules (ICAMs) (see below) (99) . Some integrins also are exploited as cell surface receptors for certain viruses (100) .
Members of the integrin superfamily are heterodimeric cell surface glycoproteins comprised of subunits α and β that each span the membrane once. To date, 16 α-subunits and 8 β-subunits have been identified. A given β-subunit can combine with one or several different α-subunits; 21 different αβ pairings are known. The extracellular part of the α-subunits has up to 1114 residues and that of the β-subunits has up to 678 residues. In each subunit the N-terminal portions form a globular ligand-binding domain that is connected to the membrane by a stalk. A subset of α chains contain an additional domain of about 190 amino acids, variously termed either the inserted (I) domain or, by analogy with homologous domains in von Willebrand Factor, the A domain (101, 102) . Mg 2+ and Ca 2+ ions are required for ligand binding. Integrins are competent to signal in response to both adhesive interactions outside the cell (outside-in) and events inside the cell (inside-out) (99, 103) . Outside-in signaling triggers processes within the cell mediated by the cytosolic domains of the α-and β-subunits. Inside-out signaling is manifest through what is believed to be a conformational switch in the extracellular region between active (adhesive) and inactive states.
Structure of the N-Terminal Domain of the Integrin α-Subunits
α-subunits have a ligand-binding N-terminal domain that consists of residues 1 to ∼440, except in those subunits that have I domains, in which it consists of residues 1 to ∼130 and ∼320 to ∼600. In all α-subunits, the sequences in this region have a sevenfold repeat, with each repeat consisting of ∼60 residues. A structure has been predicted for this domain on the basis of (a) the conservation of the sevenfold repeat in evolution, (b) sequence patterns within the repeats, (c) symmetry arguments, (d) secondary structure predictions, (e) model building, and ( f ) topology of disulphide bridges formed by cysteines (103a). Each repeat is predicted to form a four-stranded β-sheet, and the seven β-sheets, from the seven repeats, are predicted to have a pseudosymmetric radial arrangement that gives a β-propeller fold (103a; Figure 7 ).
The Metal and Ligand Binding Site in α-Subunits
All integrins have a Ca 2+ binding motif in repeats 5, 6, and 7, and some also have the motif in repeat 4 (103b). In the predicted structure, these motifs are in the link between the first and second β-sheet strands in the respective repeats. These positions put the Ca 2+ ions close to one another at the bottom of the domain, as shown in Figure 7 binding (103c, 103d) . In the predicted structure, the two regions are in interstrand loops; close to each other at the top of the domain, and at one side of the Mg 2+ site (103a; Figure 7 ). In the integrins that contain an I domain, it is inserted in the link between repeats 2 and 3. The position of this link puts the I domain close to the predicted binding site of the N-terminal domain (Figure 7) .
Structure of the I Domains
High-resolution crystal structures have been determined for the I domains of two integrins [from the α M subunit of α M β 2 (104, 105) and the α L subunit of α L β 2 (106, 107) ]. The I domains of α M and α L share 33% sequence identity, and their structures are very similar. Each has an α/β fold consisting of seven α-helices packed against a central six-stranded β-sheet (Figure 7) . The strands in the β-sheet have the order CBADEF. This topology is the same as that of the widespread dinucleotide-binding (or Rossmann) fold first observed in the intracellular enzyme, lactate dehydrogenase (108).
The Metal-Binding Site in the I Domains
A divalent cation-binding site is situated on the surface of the I domain at one end of the β-sheet, in the position classically occupied by a dinucleotide cofactor in other proteins that contain a domain with this fold. In I domain crystal structures (105) (106) (107) , the divalent metal ion is directly coordinated at the cation binding site by residues Ser-139, Ser-141, and Asp-239; Thr-206 participates indirectly through a hydrogen bond to a coordinating water molecule (the residue numbering here is for α L ; identical residues, but with different numbering, are used in α M ). A total of six ligands coordinate the metal ion with an octahedral geometry; the remaining ligands are water molecules or a chloride ion (106, 107) . The residues involved are highly conserved in the sequences of all known I domains, and this arrangement has been termed the metal ion-dependent adhesion site (MIDAS) motif (105) . The key features of this motif are the sequence DXSXS (residues 137-141) and residues Thr-206 and Asp-239.
Crystal structures have been determined for the Mg 2+ -(104) and Mn 2+ -bound (105) forms of the α M I domain. Crystal structures also have been determined for the metal-free, Mg 2+ -, and two Mn 2+ -bound (106, 107) forms of the α L I domain. For both I domains, comparisons of the various structures reveal significant shifts in the position of α7, the C-terminal helix of the domain (105, 107 triggered by differences in molecular contacts within the crystal lattices, rather than by internal changes in the protein due to metal binding state (107) .
The I-Domain Adhesion Site
The I domains of α L and α M contribute to the interaction of these integrins with IgSF-type cell adhesion molecules (109, 110) . In addition to residues in the MIDAS motif, several solvent-exposed residues in the α L I domain (Met-140, Glu-146, Thr-243, and Ser-245) have been implicated by mutagenesis studies on integrin association with ICAM-1 (111) (112) (113) . These residues map to the surface surrounding the divalent cation-binding site. Recent structural results indicate that presence of a divalent cation is not requisite for a stable I-domain fold (107); thus, the functional importance of the metal ion may be to interact directly with residues on the ICAM-1 molecule. Indeed, in many integrinbinding molecules, an acidic residue (Asp or, less frequently, Glu) has been identified as a key functional element (99, 114) , and in the Mg 2+ -bound crystal structure of the α M I domain, coordination of the metal ion is completed by a Glu side chain donated by a neighboring molecule in the crystal lattice (104) .
VASCULAR CELL ADHESION MOLECULE 1 VCAM-1 (115) is one of a subgroup of IgSF-type cell adhesion molecules whose members include the intercellular adhesion molecules, ICAM-1 (116, 117) , ICAM-2 (118), and ICAM-3 (119, 120) , and the mucosal vascular addressin cellular adhesion molecules (MAdCAMs) (121) . VCAMs, ICAMs, and MAdCAMs bind members of the integrin superfamily and play a central role in leukocyte trafficking and in extravasation (122) . In addition, the extracellular regions of several of these molecules act as cellular receptors for various viruses and parasites (123) (124) (125) (126) .
Each of these cell adhesion molecules consists of an N-terminal extracellular region built from IgSF domains, a transmembrane helix, and a cytoplasmic domain. The number and exact nature of the domains making up the extracellular regions of these molecules vary, but they all contain a two-domain integrin-binding fragment that is homologous to the two N-terminal domains of VCAM-1.
Structure of the Two N-Terminal Domains of VCAM-1
The extracellular region of VCAM-1 consists of seven (or less commonly for a splice variant, six) IgSF domains. Crystal structures for a functional fragment comprising the two N-terminal domains have been determined independently by two groups (127, 128; Figure 8) . Domain 1 has an IgSF I-set structure with two β-sheets-strands A, B, E, and D, and strands A , G, F, and C, respectively. It also has two intersheet disulphides: One is the canonical disulphide between strands B and F; the other is a distinctive feature of this subgroup and links the BC and FG loops. The structure is similar to the typical immunoglobulin I-set domain except for the CD loop, which extends from the body of the domain and displays a solvent-accessible hydrophobic residue (Ile-39) and a highly exposed acidic residue (Asp-40) (see below). To date, domain 2 of VCAM-1 is the largest IgSF C2-set domain for which a structure has been determined. The core is structurally the same as the C2-set domains in CD2 and CD4, with two β-sheets [strands A, B, and E, and strands G, F, C, and C , respectively (Figure 1) ], but the interstrand loops, most notably the C E and FG loops, are much longer. These two loops appear flexible; the FG loop shifts to accomodate small differences in the relative positions of domains 1 and 2.
The interdomain connection between VCAM-1 domains 1 and 2 is structurally homologous to that of CD2 (see below). As in CD2, this portion of the polypeptide chain is closely associated with domain 2 through hydrogen bonds to the side chains of residues in the FG loop of this domain. Again, as observed in CD2, this form of linker permits some flexibility in the relative orientation of the domains.
Integrin-Binding Sites in VCAM-1 and ICAMs
VCAM-1 binds to the integrin α 4 β 1 . The residues implicated in this adhesive function by mutagenesis (129) (130) (131) (132) (133) map to the GFC-strand face and the CD loop of the N-terminal domain. Residues that play a role in binding of integrin include Ile-39 and Asp-40, which are prominently displayed in the CD loop (Figure 8) , and nearby Leu-70 on strand F. Acidic residues, in particular Asp, have long been implicated in adhesive interactions to integrins (88, 114) .
The ICAMs bind to integrins α L β 2 and α M β 2 . In ICAM-3, residues implicated in adhesion include Glu-37, Leu-66, Ser-68, and Gln-75 (134) . Alignment of ICAM-3 with VCAM-1 (C Chothia, unpublished observations) shows that Leu-66 is in a position equivalent to that of Leu-70 in VCAM-1. Glu-37, however, is not in the CD loop (unlike Asp-40 in VCAM-1), but in the C strand. Examination of a recent structure for ICAM-2 leads to the same conclusion (J Wang, personal communication). This difference suggests that the α L β 2 and α M β 2 integrins bind via an acidic residue in a flat region (rather than one in a protruding loop, as is common with other integrins).
CD2
CD2, a protein found on the surface of cytotoxic and helper T-cells (135, 136) , enhances the cell-cell interaction mediated by binding of the αβ receptor of the T-cell to the major histocompatibility complex class I and II molecules on antigen-presenting cells. Human CD2 binds to CD58 (136) , and rat CD2 binds to CD48 (137, 138) . CD2 is homologous to both CD58 and CD48; thus, the interactions are pseudohomophilic.
CD2 is a representative of a large group of homologous cell surface receptors, which includes CD58, CD48, SLAM, 2B4, and LY-9 (139). Except for LY-9, all have an N-terminal extracellular region formed by two IgSF-type domains that are tethered to the cell surface by either a transmembrane helix and a cytoplasmic domain or by a glycosylphosphatidylinositol anchor (CD48 and an isoform of CD58). LY-9 contains four Ig domains (perhaps as the result of gene duplication). Sequence analysis also indicates that CD2 is homologous to the N-terminal two domains of members of the carcinoembryonic-antigen (CEA) subset of IgSF molecules (140) .
Structure of the CD2 Extracellular Domains
The crystal structures of rat and human CD2 were the first determined for the entire extracellular portions of a cell adhesion molecule (141, 142; Figure 9 ). Both structures are very similar and agree well with solution structures determined by nuclear magnetic resonance (NMR) (143, 144) .
The N-terminal domain of CD2 has an IgSF V-set structure with two β-sheets-one formed by strands A , G, F, C, C , and C , and the other by strands B, E, and D. This domain in CD2 differs from canonical V-set structures in two respects: absence of both an initial A strand and a disulphide between strands B and F (141) (142) (143) (144) . The disulphide is absent in all members of the CD2 subset. Normally, in V-set domains, strand A hydrogen-bonds to the B strand before switching to hydrogen-bond, as strand A , to the G strand. Absence of an A strand may not be a general feature of the CD2 group because sequence analysis indicates appropriately positioned residues before a Pro at the predicted start of strand A in, for example, CD58 and SLAM.
The second domain in CD2 has a typical IgSF C2-set structure (12) with two β-sheets-one formed by strands A, B, and E, and the other by strands G, F, C, and C (141) (142) . In this domain of CD2, an intersheet disulphide links strands B and F, as found in standard Ig domains; but a distinctive feature of the second domain in CD2 is a second disulphide linking the ends of strands A and G. The arrangement of a V-set domain followed by a C2-set domain seen in CD2 is also found in CD4 (146) (147) (148) .
Connections Between IgSF Domains in CD2 and Other Proteins
In CD2, the V-set domain is connected to the C2-set domain by a discrete linker of six residues. Sequence analysis indicates that homologous connections, characterized by the residues ExVskP, are present in other members of this IgSF subgroup. that the domains can flex about 7
• relative to one another. A second region of flexibility in the extracellular portion of the CD2 molecule is provided by a short stalk of some six residues that tethers the second Ig domain to the transmembrane helix.
In Table 2 , we describe the interdomain geometries of other linked IgSF domains. The first and second domains of VCAM are linked in a manner closely related to that in CD2 and have a similar geometry. Links of a similar type are also predicted, on the basis of sequence homology, to be present in certain other IgSF-type cell surface receptors (70). CD4 has four domains: The first and third have a V-set structure; the second and fourth have a C2-set structure. Unlike in CD2, the V domains in CD4 are linked directly to the C2 domains. In other words, at the boundaries between domains 1 and 2 and between domains 3 and 4 in CD4, the last residue in strand G of the V-set domain is followed by the first residue in strand A of the C2-set domain (rather than connected by the linker found in CD2). This form of interdomain linkage would appear to be rigid (145) (146) (147) (148) (149) . Although the structure of the interdomain links in CD4 is quite different from that in CD2, the V domains and C2 domains have similar relative interdomain geometries (Table 2) . In antibodies, the connection between the V and C domains includes a molecular "ball and socket joint" that allows the V L -V H dimer to rotate relative to the C L -C H1 dimer and give tilt angles that range between ∼135 and ∼180
• (150) .
CD2 Adhesion Site
CD2 does not exhibit true homophilic adhesion at physiological conditions (151), but given the homology between CD2 and its ligands, the functional interactions between members of this IgSF subgroup are presumably pseudohomophilic. Indeed, the only intermolecular lattice contacts common to crystals of both rat and human CD2 are "head-to-head" interactions between the GFCC C β-sheets of domain 1 (142; Figure 9 ). This association places the two molecules in an orientation appropriate to their function as intercellular adhesion molecules. Thus, it was proposed that this binding mode provides a good model for the adhesive interaction (141). This hypothesis is now supported by a broad range of data. Mutagenesis data implicate residues on the GFCC C face of the N-terminal domain of both rat and human CD2 in adhesion in vivo (152) (153) (154) (155) . Likewise, mutagenesis of homologous residues in CD48 (156) confirms the location of a functional adhesive site at this same position on this molecule. Analysis of the interactions of rat CD2 and CD48 by solution NMR showed good agreement with the crystallographic model for the adhesive area on CD2 (157) .
Taken together, these data indicate that the adhesive area on domain 1 of CD2 extends over the length of strands C and C , the C-terminal half of strand F, and the N-terminal half of strand G. This surface has an area of approximately 750Å 2 , is flat, and is made up predominantly of charged or polar residues. In particular, both crystallographic (141, 142) and solution NMR (157) data implicate rat CD2 residues Glu-29, Arg-31, Glu-33, Thr-37, Leu-38, Glu-41, Lys-43, Phe-49, Thr-79, Tyr-81, and Gly-85 as central to the adhesive interaction.
The crystallographic model for adhesion has been further tested using complementary mutagenesis of rat CD2 and CD48 (156). The ability of charge reversal mutations in one molecule to compensate for charge reversal mutations in the other molecule indicates that residues Glu-41 and Lys-43 of rat CD2 interact with residues Arg-31 and Glu-44 of CD48, respectively. These results are in good agreement with the model, in which the CC and FG loops of opposing molecules are paired, and the angle between the strand directions of the two β-sheets is approximately 90
• (Figure 9 ).
CONCLUSIONS
Among proteins of known structure, cell adhesion molecules have quite novel functions. These cell-surface proteins use specific homophilic or heterophilic recognition to either bind cells together or facilitate their movement on a substratum. To what extent are these novel functions reflected in novel structural properties? For an initial answer to this question, the cell adhesion molecules described here can be compared with other molecules whose structures are known, particularly those whose function involves protein-protein recognition.
The folds of the individual domains in the cell adhesion molecules described here are in no way novel. They either have β-sheets packed face-to-face or α-helices packed onto the faces of a β-sheet. Folds of this kind are found in many proteins with a great variety of functions [see the entries in the Structural Classification of Proteins (SCOP) database (158)].
The arrangement of domains as linear arrays, as observed in cell adhesion molecules and other cell surface proteins, is rare in proteins of the cytoplasm, but does occur. In certain structural proteins, the arrays can be much longer and can be built of domains related to those found in cell adhesion molecules. For example, the muscle protein titin contains 112 IgSF I-set domains and 132 FnIII domains (16, 159) . In the gene sequences of cell adhesion molecules, the coding regions for domains are usually separated at the domain boundaries by introns. This finding suggests that cell adhesion molecules have evolved through gene duplication and interintronic recombination; it has been argued that this process was crucial to form new large proteins in the development of the metazoa (160) . The recognition sites seen in the cadherins, CD2, and to a lesser extent P 0 have structures very similar to those seen in stable complexes between soluble proteins. For example, the areas buried in recognition sites of protease-inhibitor and antibody-protein antigen complexes have the same range of values (29) . The very extended binding surface that seems to be formed in the NCAM adhesion dimer is very different from typical soluble protein-protein complexes, but it does occur in muscle proteins.
The kinetics of adhesive interactions of leukocyte adhesion molecules are different from those found for the high-affinity complexes formed by soluble proteins. Measurements of the rates of association and dissociation have been made for both the soluble extracellular portions of these adhesion molecules, and the intact molecules attached to cell membranes (161) (162) (163) . In both cases, the dissociation rate constant (k off ) is much faster than those characteristically found for high-affinity interactions between soluble proteins: ∼5 s −1 rather than ∼10 −4 s −1 . Adhesion molecules on the surface of leukocytes facilitate both rapid migration over endothelial surfaces and stable adhesion to target cells. It has been argued that the dynamic role of a cell adhesion molecule requires rapid association and disassociation of its adhesive bonds (161) .
Measurements in solution of the association rate constant (k on ) for leukocyte adhesion molecules give values similar to, or a little less than, those for highaffinity interactions between soluble proteins, ∼10 −5 M −1 s −1 (161) . Therefore, for a leukocyte cell adhesion molecule, the equilibrium constant in solution (K d ) is 10 −5 -10 −4 M. This range of affinity is much smaller than that found for the tight-binding complexes between soluble proteins, which usually have a K d in the range 10 −8 -10 −13 M. However, adhesion molecules on cells are tethered to the surface and therefore restricted to movement in two dimensions (unlike soluble molecules in solution). Also, lateral mobility in the membrane facilitates concentration of cell adhesion molecules at sites of cell-cell contact (163) . In experiments using CD2 on T-cells and purified CD58 in artificial phospholipid bilayers, the affinity constant was shown to be so high that complex formation was strongly favored under physiological conditions (162, 163) . Thus, cell adhesion molecules have evolved novel binding sites that possess intrinsic association and dissociation constants that permit both high-affinity cell-cell interactions and rapid cell migration.
